Genor Biopharma Holdings Limited's total assets for Q4 2024 were ¥1.29B, a decrease of 0.00% from the previous quarter. DE:67N0 total liabilities were ¥138.05M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.